It is of note that the pathological hallmark of CADASIL, GOM, was not detected in either of these patients (Fouillade et al., 2008; Pippucci et al., 2015), suggesting that arteriopathy related to abnormal NOTCH3 signaling is different from CADASIL. The gene discussed is NOTCH3; the disease is CADASIL.